Neuromarkers Pllc

Medical research on brain disease, including epidemiology, genetics, diagnosis, prognosis and treatment for central nervous system (CNS) pediatric and adult tumors, cerebrovascular disease, infections and inflammatory diseases, and metabolic/neurodegenerative diseases.

(1) Internal grant NM2025-26-1 for study of the NF1-mutant glioblastoma, benefiting the entire adult population: Prospective integrated analysis with survival significance of NF1-mutant glioblastoma forming the G3/NF1 molecular subgroup.

2) Internal grant NM2025-26-2 for study of adult diffuse midline glioma, benefiting the entire population: Contribution to the knowledge of molecular pathology and neuroimaging. Spinal astrocytoma; DOI: 10.24875/RAR.M26000061.

Neuromarkers Pllc is a 501(c)(3) nonprofit (EIN 84-2423243) based in Houston, TX.